CLINICAL_TRIALS
research
· 2025-09-03
Clinical Trial Update: [18F]FLT PET/CT in Rb+ Metastatic Breast Cancer [Phase 1]
Summary
Phase 1 clinical trial evaluating [18F]FLT PET/CT imaging in RB-positive metastatic breast cancer; status is active but not recruiting.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: University of Pennsylvania | Conditions: Breast Neoplasm, Metastatic Breast Cancer | Phase 1 | Status: ACTIVE_NOT_RECRUITING